There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC – Research Report), Acrivon Therapeutics, Inc. (ACRV – Research Report) and Viking Therapeutics (VKTX – Research Report) with bullish sentiments.
CalciMedica (CALC)
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on CalciMedica, with a price target of $14.00. The company’s shares closed last Wednesday at $5.49.
According to TipRanks.com, Gershell is a 2-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CalciMedica with a $18.67 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Acrivon Therapeutics, Inc. (ACRV)
Oppenheimer analyst Matthew Biegler maintained a Buy rating on Acrivon Therapeutics, Inc. today and set a price target of $21.00. The company’s shares closed last Wednesday at $9.50.
According to TipRanks.com, Biegler is a 1-star analyst with an average return of
Acrivon Therapeutics, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $21.71, which is a 122.0% upside from current levels. In a report issued on April 22, JonesTrading also maintained a Buy rating on the stock with a $26.00 price target.
Viking Therapeutics (VKTX)
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Viking Therapeutics, with a price target of $138.00. The company’s shares closed last Wednesday at $65.07.
According to TipRanks.com, Olson is a 5-star analyst with an average return of
Currently, the analyst consensus on Viking Therapeutics is a Strong Buy with an average price target of $113.50, a 72.6% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $90.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CALC:
